According to Franklin Covey's latest financial reports the company's total liabilities are $0.15 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-08-31 | $0.16 B | -5.15% |
2022-08-31 | $0.17 B | 3.86% |
2021-08-31 | $0.16 B | 16.31% |
2020-08-31 | $0.14 B | 2.16% |
2019-08-31 | $0.14 B | 7.14% |
2018-08-31 | $0.13 B | 6.13% |
2017-08-31 | $0.12 B | 29.34% |
2016-08-31 | $97.15 M | 29.3% |
2015-08-31 | $75.13 M | -4.25% |
2014-08-31 | $78.47 M | -5.34% |
2013-08-31 | $82.89 M | 12.75% |
2012-08-31 | $73.52 M | 1.96% |
2011-08-31 | $72.11 M | -7.51% |
2010-08-31 | $77.97 M | 4.13% |
2009-08-31 | $74.87 M | -24.75% |
2008-08-31 | $99.5 M | 3.96% |
2007-08-31 | $95.71 M | 15.02% |
2006-08-31 | $83.21 M | -17.13% |
2005-08-31 | $0.10 B | 45.21% |
2004-08-31 | $69.14 M | -6.48% |
2003-08-31 | $73.94 M | 5.35% |
2002-08-31 | $70.18 M | -69.03% |
2001-08-31 | $0.22 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Spero Therapeutics SPRO | $75.49 M | -50.04% | ๐บ๐ธ USA |
Universal Technical Institute UTI | $0.51 B | 237.66% | ๐บ๐ธ USA |